![Nifedipine gastrointestinal therapeutic system (GITS) as an alternative to slow-release for tocolysis—Tolerance and pharmacokinetic profile - European Journal of Obstetrics and Gynecology and Reproductive Biology Nifedipine gastrointestinal therapeutic system (GITS) as an alternative to slow-release for tocolysis—Tolerance and pharmacokinetic profile - European Journal of Obstetrics and Gynecology and Reproductive Biology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c3b53070-852c-4c96-9b24-f410d4589eaf/gr1_lrg.jpg)
Nifedipine gastrointestinal therapeutic system (GITS) as an alternative to slow-release for tocolysis—Tolerance and pharmacokinetic profile - European Journal of Obstetrics and Gynecology and Reproductive Biology
![Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial - The Lancet Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/1f478c62-04fd-4e46-a3f9-84ad6e7b85e2/gr1.gif)
Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial - The Lancet
![PDF) Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: A phase III, randomized, double-blind and parallel-group study PDF) Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: A phase III, randomized, double-blind and parallel-group study](https://i1.rgstatic.net/publication/255954788_Nifedipine_controlled-release_40_mg_bid_in_Japanese_patients_with_essential_hypertension_who_responded_insufficiently_to_nifedipine_controlled-release_40_mg_qd_A_phase_III_randomized_double-blind_and_/links/00b7d531e456d90bde000000/largepreview.png)
PDF) Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: A phase III, randomized, double-blind and parallel-group study
![Comparative effectiveness of generic nifedipine versus Adalat long‐acting nifedipine for hypertension treatment: A multi‐institutional cohort study - Tung - 2022 - The Journal of Clinical Hypertension - Wiley Online Library Comparative effectiveness of generic nifedipine versus Adalat long‐acting nifedipine for hypertension treatment: A multi‐institutional cohort study - Tung - 2022 - The Journal of Clinical Hypertension - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9ce30378-a4c5-4095-af30-aad76ace8604/jch14478-fig-0001-m.jpg)
Comparative effectiveness of generic nifedipine versus Adalat long‐acting nifedipine for hypertension treatment: A multi‐institutional cohort study - Tung - 2022 - The Journal of Clinical Hypertension - Wiley Online Library
![Comparative effectiveness of generic nifedipine versus Adalat long‐acting nifedipine for hypertension treatment: A multi‐institutional cohort study - Tung - 2022 - The Journal of Clinical Hypertension - Wiley Online Library Comparative effectiveness of generic nifedipine versus Adalat long‐acting nifedipine for hypertension treatment: A multi‐institutional cohort study - Tung - 2022 - The Journal of Clinical Hypertension - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ae55804c-1ef6-486e-b104-f30524be1299/jch14478-fig-0002-m.jpg)
Comparative effectiveness of generic nifedipine versus Adalat long‐acting nifedipine for hypertension treatment: A multi‐institutional cohort study - Tung - 2022 - The Journal of Clinical Hypertension - Wiley Online Library
![PDF) Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: A phase III, randomized, double-blind and parallel-group study PDF) Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: A phase III, randomized, double-blind and parallel-group study](https://www.researchgate.net/profile/Yuhei-Kawano/publication/255954788/figure/fig1/AS:267433453813764@1440772512669/Change-from-baseline-in-a-trough-seated-diastolic-blood-pressure-DBP-b-trough_Q320.jpg)
PDF) Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: A phase III, randomized, double-blind and parallel-group study
![A–D) Inhibitory effect of acetohexamide, nifedipin, proadifen and... | Download High-Quality Scientific Diagram A–D) Inhibitory effect of acetohexamide, nifedipin, proadifen and... | Download High-Quality Scientific Diagram](https://www.researchgate.net/publication/234089179/figure/fig2/AS:202893245325327@1425384927477/A-D-Inhibitory-effect-of-acetohexamide-nifedipin-proadifen-and-isoxsuprine-on-CCID.png)
A–D) Inhibitory effect of acetohexamide, nifedipin, proadifen and... | Download High-Quality Scientific Diagram
![Estimation of Crystallinity of Nifedipine–Polyvinylpyrrolidone Solid Dispersion by Usage of Terahertz Time-Domain Spectroscopy and of X-Ray Powder Diffractometer - Journal of Pharmaceutical Sciences Estimation of Crystallinity of Nifedipine–Polyvinylpyrrolidone Solid Dispersion by Usage of Terahertz Time-Domain Spectroscopy and of X-Ray Powder Diffractometer - Journal of Pharmaceutical Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2102225402/2080210361/gr1.jpg)
Estimation of Crystallinity of Nifedipine–Polyvinylpyrrolidone Solid Dispersion by Usage of Terahertz Time-Domain Spectroscopy and of X-Ray Powder Diffractometer - Journal of Pharmaceutical Sciences
![PDF) Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: Further analysis of the 'ACTION' database in patients with angina PDF) Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: Further analysis of the 'ACTION' database in patients with angina](https://www.researchgate.net/profile/Peter-Meredith-2/publication/41562665/figure/fig1/AS:267479712792579@1440783541107/The-effect-of-nifedipine-GITS-on-pre-defined-end-points-in-patients-with-ISH-at-baseline_Q320.jpg)
PDF) Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: Further analysis of the 'ACTION' database in patients with angina
![Comparison of short-acting versus extended-release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease | Scientific Reports Comparison of short-acting versus extended-release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-56890-1/MediaObjects/41598_2019_56890_Fig1_HTML.png)
Comparison of short-acting versus extended-release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease | Scientific Reports
![In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen | British Journal of Cancer In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fbjc.2012.580/MediaObjects/41416_2013_Article_BFbjc2012580_Fig2_HTML.jpg)
In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen | British Journal of Cancer
ChemIDplus - 21829-25-4 - HYIMSNHJOBLJNT-UHFFFAOYSA-N - Nifedipine [USAN:USP:INN:BAN:JAN] - Similar structures search, synonyms, formulas, resource links, and other chemical information.
![Nifedipine, Calcium Channel Blocker (Antihypertensive), as a Tocolytic to inhibit Premature Birth in Reducing the Risk of Neonatal Death in Childbirth: Meta-Analysis and Systematic Review of Large Clinical Trial | Indonesian Journal Nifedipine, Calcium Channel Blocker (Antihypertensive), as a Tocolytic to inhibit Premature Birth in Reducing the Risk of Neonatal Death in Childbirth: Meta-Analysis and Systematic Review of Large Clinical Trial | Indonesian Journal](https://www.inajog.com/public/journals/1/cover_issue_72_en_US.jpg)
Nifedipine, Calcium Channel Blocker (Antihypertensive), as a Tocolytic to inhibit Premature Birth in Reducing the Risk of Neonatal Death in Childbirth: Meta-Analysis and Systematic Review of Large Clinical Trial | Indonesian Journal
![Comparison of short-acting versus extended-release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease | Scientific Reports Comparison of short-acting versus extended-release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-56890-1/MediaObjects/41598_2019_56890_Fig2_HTML.png)
Comparison of short-acting versus extended-release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease | Scientific Reports
![Effect of acetohexamide, nifedipin, proadifen and isoxsuprine on ALOX12... | Download High-Quality Scientific Diagram Effect of acetohexamide, nifedipin, proadifen and isoxsuprine on ALOX12... | Download High-Quality Scientific Diagram](https://www.researchgate.net/publication/234089179/figure/fig3/AS:202893245325331@1425384927515/Effect-of-acetohexamide-nifedipin-proadifen-and-isoxsuprine-on-ALOX12-activity.png)